Search results
Showing 2701 to 2715 of 7688 results
Interventional procedures programme manual
Good practice guidance – Interim process statement
Evidence summaries: process guide
User guide for the cost comparison company evidence submission template (PMG32)
User guide for the cost comparison company evidence submission template
Medical technologies evaluation programme methods guide (PMG33)
Medical technologies evaluation programme methods guide
Show all sections
- 1 Introduction
- 2 The medical technologies evaluation programme
- 3 Selecting and routing technologies
- 4 Principles for developing medical technologies guidance
- 5 Scope
- 6 Evidence and expert advice
- 7 Evidence synthesis and cost-consequence analysis
- 8 Evaluation of the evidence and decision-making by the committee
Medical technologies evaluation programme process guide (PMG34)
Medical technologies evaluation programme process guide
Show all sections
- 1 Introduction
- 2 The medical technologies evaluation programme
- 3 Who is involved in the medical technologies evaluation programme
- 4 Identifying, selecting and routing technologies for evaluation
- 5 How medical technologies guidance is developed
- 6 Resolution
- 7 Publishing medical technologies guidance
- 8 Reviews
Single technology appraisal and highly specialised technologies evaluation: User guide for company evidence submission template
Evidence summaries: new medicines – Integrated process statement (PMG11)
Evidence summaries: new medicines – Integrated process statement
Good practice guidance – Integrated process statement (PMG12)
Good practice guidance – Integrated process statement
Guide to the technology appraisal and highly specialised technologies appeal process (pre June 2023)
Interim clinical guideline surveillance process and methods guide 2013 (PMG16)
Interim clinical guideline surveillance process and methods guide 2013
Show all sections
Interim process and methods guide for the clinical guideline updates using standing committees pilot programme 2013
Evidence summaries: unlicensed and off-label medicines – Integrated process statement (PMG14)
Evidence summaries: unlicensed and off-label medicines – Integrated process statement
Evidence summaries: new medicines – Interim process statement (PMG1)
Evidence summaries: new medicines – Interim process statement
The social care guidance manual
Show all sections
- 1 Introduction
- 2 The scope
- 3 The Guidance Development Group
- 4 Developing review questions and planning the systematic review
- 5 Identifying the evidence: literature searching and evidence submission
- 6 Reviewing the evidence
- 7 Incorporating economic evaluation
- 8 Linking social care guidance to other NICE guidance